144 related articles for article (PubMed ID: 15205198)
1. Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial.
Stathopoulos GP; Veslemes M; Georgatou N; Antoniou D; Giamboudakis P; Katis K; Tsavdaridis D; Rigatos SK; Dimitroulis I; Bastani S; Loukides S; Vergos K; Marossis K; Grigoratou T; Kalatzi E; Charalambatou M; Paspalli A; Michalopoulou P; Stoka M; Gerogianni A
Ann Oncol; 2004 Jul; 15(7):1048-55. PubMed ID: 15205198
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.
Saito H; Nakagawa K; Takeda K; Iwamoto Y; Ando M; Maeda M; Katakami N; Nakano T; Kurata T; Fukuoka M
Am J Clin Oncol; 2012 Feb; 35(1):58-63. PubMed ID: 21293243
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Kelly K; Crowley J; Bunn PA; Presant CA; Grevstad PK; Moinpour CM; Ramsey SD; Wozniak AJ; Weiss GR; Moore DF; Israel VK; Livingston RB; Gandara DR
J Clin Oncol; 2001 Jul; 19(13):3210-8. PubMed ID: 11432888
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Comella P; Frasci G; De Cataldis G; Panza N; Cioffi R; Curcio C; Belli M; Bianco A; Ianniello G; Maiorino L; Della Vittoria M; Perchard J; Comella G
Br J Cancer; 1996 Dec; 74(11):1805-11. PubMed ID: 8956797
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.
Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J
Lung Cancer; 2001 May; 32(2):173-8. PubMed ID: 11325488
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD
Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
[TBL] [Abstract][Full Text] [Related]
8. Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.
Pallis AG; Syrigos K; Kotsakis A; Karachaliou N; Polyzos A; Chandrinos V; Varthalitis I; Christophyllakis C; Ardavanis A; Vamvakas L; Vardakis N; Saridaki Z; Samonis G; Giassas S; Georgoulias V; Agelaki S
Clin Lung Cancer; 2011 Mar; 12(2):100-5. PubMed ID: 21550556
[TBL] [Abstract][Full Text] [Related]
9. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.
Rosell R; Gatzemeier U; Betticher DC; Keppler U; Macha HN; Pirker R; Berthet P; Breau JL; Lianes P; Nicholson M; Ardizzoni A; Chemaissani A; Bogaerts J; Gallant G
Ann Oncol; 2002 Oct; 13(10):1539-49. PubMed ID: 12377641
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer.
Belani CP;
Semin Oncol; 2002 Jun; 29(3 Suppl 12):4-9. PubMed ID: 12170445
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients.
Schmittel A; Siehl JM; Schulze M; Schulze K; Thiel E; Keilholz U
Anticancer Res; 2005; 25(2B):1333-6. PubMed ID: 15865087
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.
Greco FA; Spigel DR; Kuzur ME; Shipley D; Gray JR; Thompson DS; Burris HA; Yardley DA; Pati A; Webb CD; Gandhi JG; Hainsworth JD
Clin Lung Cancer; 2007 Sep; 8(8):483-7. PubMed ID: 17922972
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.
Takayama K; Inoue K; Tokunaga S; Matsumoto T; Oshima T; Kawasaki M; Imanaga T; Kuba M; Takeshita M; Harada T; Shioyama Y; Nakanishi Y
Cancer Chemother Pharmacol; 2013 Dec; 72(6):1353-9. PubMed ID: 24166107
[TBL] [Abstract][Full Text] [Related]
14. Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902.
LeCaer H; Delhoume JY; Thomas PA; Berard H; Paillotin D; Barriere JR; Gimenez C; Vergnenegre A; Muller P; Auquier P; Perol M
Clin Lung Cancer; 2005 Sep; 7(2):114-20. PubMed ID: 16179098
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.
Masters GA; Hahn EA; Shevrin DH; Kies MS
Lung Cancer; 2003 Feb; 39(2):221-6. PubMed ID: 12581577
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
[TBL] [Abstract][Full Text] [Related]
17. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.
Robinet G; Thomas P; Breton JL; Léna H; Gouva S; Dabouis G; Bennouna J; Souquet PJ; Balmes P; Thiberville L; Fournel P; Quoix E; Riou R; Rebattu P; Pérol M; Paillotin D; Mornex F
Ann Oncol; 2001 Jan; 12(1):59-67. PubMed ID: 11249050
[TBL] [Abstract][Full Text] [Related]
18. Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer.
Lilenbaum RC; Chen CS; Chidiac T; Schwarzenberger PO; Thant M; Versola M; Lane SR
Ann Oncol; 2005 Jan; 16(1):97-101. PubMed ID: 15598945
[TBL] [Abstract][Full Text] [Related]
19. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.
Socinski MA; Schell MJ; Peterman A; Bakri K; Yates S; Gitten R; Unger P; Lee J; Lee JH; Tynan M; Moore M; Kies MS
J Clin Oncol; 2002 Mar; 20(5):1335-43. PubMed ID: 11870177
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas.
Alici S; Coskun U; Alkis N; Sevinc A; Dane F; Gumus M; Ozkan M; Kaya AO; Celenkoglu G; Buyukberber S; Altunbas M; Benekli M;
Asian Pac J Cancer Prev; 2009; 10(6):1051-5. PubMed ID: 20192582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]